{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:39:31Z","timestamp":1780393171662,"version":"3.54.1"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.3201\/eid2408.180228","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T12:51:33Z","timestamp":1530190293000},"page":"1561-1564","source":"Crossref","is-referenced-by-count":45,"title":["Fatal Nongroupable <i>Neisseria meningitidis<\/i> Disease in Vaccinated Patient Receiving Eculizumab"],"prefix":"10.3201","volume":"24","author":[{"given":"Deirdre","family":"Nolfi-Donegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Konar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianca","family":"Vianzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrianne","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judi","family":"Sedivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2408.180228-201807171022-R1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children.","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.3201\/eid2408.180228-201807171022-R2","unstructured":"Alexion Pharmaceuticals, Inc. Soliris. Revised 1\/2016 [package insert] [cited 2016 Dec 2]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/125166s417lbl.pdf"},{"key":"key-10.3201\/eid2408.180228-201807171022-R3","unstructured":"Alexion Pharmaceuticals, Inc. Soliris REMS (Risk Evaluation and Mitigation Strategy) [cited 2017 Jul 23]. http:\/\/www.solirisrems.com"},{"key":"key-10.3201\/eid2408.180228-201807171022-R4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cmi.2017.07.011","article-title":"Post-eculizumab meningococcaemia in vaccinated patients.","volume":"24","author":"Lebel","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2408.180228-201807171022-R5","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1542\/peds.2014-3503","article-title":"Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome.","volume":"135","author":"Cullinan","year":"2015","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2408.180228-201807171022-R6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/ajt.12032","article-title":"Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.","volume":"13","author":"Struijk","year":"2013","journal-title":"Am J Transplant"},{"key":"key-10.3201\/eid2408.180228-201807171022-R7","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1016\/j.vaccine.2017.06.020","article-title":"The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.","volume":"35","author":"Partridge","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2408.180228-201807171022-R8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/cid\/cix519","article-title":"Serum bactericidal antibody responses of students immunized with a meningococcal serogroup B vaccine in response to an outbreak on a university campus.","volume":"65","author":"Lujan","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2408.180228-201807171022-R9","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.","volume":"186","author":"Beernink","year":"2011","journal-title":"J Immunol"},{"key":"key-10.3201\/eid2408.180228-201807171022-R10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.","volume":"350","author":"Hillmen","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2408.180228-201807171022-R11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"key-10.3201\/eid2408.180228-201807171022-R12","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.","volume":"102","author":"Sprong","year":"2003","journal-title":"Blood"},{"key":"key-10.3201\/eid2408.180228-201807171022-R13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine.","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2408.180228-201807171022-R14","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2408.180228-201807171022-R15","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1016\/j.vaccine.2011.06.025","article-title":"Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.","volume":"29","author":"Marsh","year":"2011","journal-title":"Vaccine"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/24\/8\/18-0228_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:24:39Z","timestamp":1732987479000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/24\/8\/18-0228_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2408.180228","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}